Inaktiver Wert

Andere Sprachen Venn Life Sciences Holdings London S.E.

Aktien

HVIVO swings to profit and commences annual dividends as outlook rosy	09.04.
HVIVO plc Provides Revenue Guidance for the Year 2024	09.04.
HVIVO plc Reports Earnings Results for the Full Year Ended December 31, 2023	09.04.
European Green Transition starts trading on London's AIM market	08.04.
Investment firm European Green Transition plans listing on AIM	18.03.
HVIVO Chair and non-exec director sell 30.0 million shares	14.02.
Hvivo Completes Secondary Placing	14.02.
HVIVO directors to sell total of 14 million shares	14.02.
Hvivo Shareholders Plan Secondary Placing to Sell 14 Million Shares	14.02.
FTSE 100 Ends on Three-Week High, Partly on Diageo Rebound	30.01.
HVIVO shares up after "record year" across all metrics	30.01.
Hvivo Wins GBP6 Million Antiviral Testing Contract	02.01.
HVIVO inks GBP6.3 million deal to test common cold treatment	02.01.
New Year begins largely green amid slew of PMIs	02.01.
HVIVO plc Signs £6.3 Million Human Challenge Study Model	02.01.
Hvivo Secures GBP17 Million Contract for RSV Antiviral Drug Testing; Stock Surges	13.12.
HVIVO signs deal to test RSV antiviral drug candidate with study model	13.12.
HVIVO celebrates positive results for Pneumagen's Neumifil in trial	05.10.23
HVIVO interim profit jumps on revenue increase; ups full-year guidance	12.09.23
HVIVO : Interim Results 2023	12.09.23

Keine Ergebnisse zu dieser Suche